OUR CLINICAL TRIALS

  • Reset


A prospective, randomized, open label, clinical trial to determine whether adjuvant treatment with zoledronic acid Leer mas
Randomized Phase II trial with cetuximab and cisplatin in the treatment of ER-negative, PgRnegative, HER2-negative Leer mas
An international, multi-center, open-label, 2-arm phase III trial of adjuvant bevacizumab in triple-negative breast cancer Leer mas
A phase III, randomized, open label, multicenter, controlled trial of niraparib versus physician’s choice in Leer mas
Randomized double-blind phase II trial of exemestane (Aromasin®) plus dasatinib versus exemestane plus placebo in Leer mas
A phase II, open-label, multicenter clinical trial of pegylated liposomal doxorubicin (Caelyx®) as primary treatment Leer mas
Analysis of “CDKs 4/6” efficacy in combination with hormone treatment in HR+ HER2 negative breast Leer mas
A Phase 2 Clinical Trial of multi-agent Chemotherapy or letrozole plus Ribociclib (LEE011) as neoadjuvant Leer mas

COLLABORATE